机译:下一代肾上腺皮质癌测序揭示了靶向治疗的新途径
Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA,Foundation Medicine, Inc., Cambridge, Massachusetts, USA,Department of Pathology, Albany Medical College, Mail Code 81, 47 New Scotland Avenue, Albany, NY 12208, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA;
Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
Foundation Medicine, Inc., Cambridge, Massachusetts, USA;
机译:通过下一代测序对复发性和转移性腺样囊性癌的全面基因组分析揭示了靶向治疗的潜在新途径
机译:下一代测序揭示了靶向治疗肝内胆管癌的新途径
机译:下一代测序揭示了靶向治疗肝内胆管癌的新途径
机译:人类肝脏基因组DNA中5-(羟)甲基胞嘧啶的靶向分析:富含靶DNA的下一代测序揭示了胞嘧啶甲基化和羟甲基化的意料之外的高度个体差异
机译:下一代测序揭示了RNA的末端分化后命运。
机译:下一代肾上腺皮质癌测序揭示了靶向治疗的新途径
机译:肾上腺皮质癌的下一代测序显示出目标疗法的新途径